GlassScriptPhysician profile
Madhulika Goyal
NPI 1790728244
$1,245.83
in general payments reported to CMS, 2019-2025
7 companies · $607 in 2025
The $607 reported for 2025 was more than what 95% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $123 · 2023: $26.61 · 2024: $364 · 2025: $607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $998.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $997.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $392.91 | 2024-2025 | |
| Xeris Pharmaceuticals, INC. | $250.00 | 2024-2025 | Gvoke Hypopen |
| Cequr Corporation | $212.50 | 2024-2025 | Cequr Simplicity |
| Boston Scientific Corporation | $125.00 | 2021 | |
| Mallinckrodt Hospital Products INC. | $123.25 | 2022 | |
| Dexcom, INC. | $115.56 | 2025 | Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161) |
| Intuity Medical INC | $26.61 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madhulika Goyal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.